x lethal factor//Nature.- 2001. - Vol. 414. - P. 229-233.
. Голубовський О.А. Інфекційні хвороби.- Київ: ВСВ «Медицина».- 2012. - С. 728.
. Tetanus/J.J. Farrar, L.M. Yen, Т. Cook and others//Journal of Neurology, Neurosurgery, and Psychiatry.- 2000. - Vol. 69, №3.- Р. 292-301.
. Lalli G., Gschmeissner S., Schiavo G. Myosin Va and microtubule-based motors are required for fast axonal retrograde transport of tetanus toxin in motor neurons//Journal of Cell Science.- 2003. - Vol. 116, №22. Р. 4639-4650.
. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin/G. Schiavo; F. Benfenati; B. Poulain and others//Nature.- 1992. - Vol. 359. P. 832-835.
. Bhakdi S., Tranum Jensen J. Alpha-toxin of Staphylococcus aureus//Microbiol Reviews.- 1991. - Vol. 55, №4.- P. 733-751.
. Tomita T., Kamio Y. Molecular biology of the pore-forming cytolysins from Staphylococcus aureus, alpha - and gamma-hemolysins and leukocidin//Biosci Biotechnol Biochem.- 1997. - Vol. 61, №4. Р. 565-572.
. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore/L. Song, MR Hobaugh, C. Shustak and others//Science.- 1996. - Vol. 274. - P.1859-1866.
. Membrane insertion: the strategies of toxins/C. Lesieur, SB Vecsey, L. Abrami and others//Molecular Membrane Biology.- 1997. - Vol. 14. - P. 45-64.
. Clare K. Schmitt, Karen C. Meysick, Alison D. O Brien Bacterial Toxins: Friends or Foes?// Emerging Infectious Diseases.- 1999. Vol.5, №2.- Р. 224-233.
. Harnett M.M. Analysis of G-proteins regulating signal transduction pathways//Methods of Molecular Biology.- 1994. - Vol. 27. - P. 199-211.
. Identification of the predominant substrate for ADP-ribosylation by islet activating protein/GM Bokoch, T. Katada, J.K. Northup//The Journal of Biolical Chemistry.- 1983. - Vol.258.- P. 2072-2075.
. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals//Cell.- 1995. - Vol. 80. - P. 249-257.
. Pastan I. Targeted therapy of cancer with recombinant immunotoxins//Biochim Biophys Acta.- 1997. - Vol. 1333. - P.1-6.
. Ghetie M.A., Ghetie V., Vitetta E.S. Immunotoxins for the treatment of B-cell lymphomas//Molecular Medicine.- 1997. - Vol. 3, №7.- P.420-427.
. The emerging role of immunotoxins in leukemia and lymphoma/U. Winkler, S. Barth, R. Schnell and others//Annals of Oncology.- 1997. - Vol.8, №1.- P.139-146.
. Murray LJ, Habeshaw JA, Wiels J. Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells//Int. J. Cancer.- 1985. - Vol.36.- P.561-565.
. Taga S., Mangeney M., Tursz T. Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt s lymphoma cell lines//Int. J. Cancer.- 1995. - Vol. 61. - P. 261-267.
. LaCasse EC, Saleh MT, Patterson B. Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice//Blood.- 1996. - Vol. 88, №5.- P.1551-1567.
. Kessler KR, Benecke R. Botulinum toxin: from poison to remedy//Neurotoxicology.- 1997. - Vol. 18. - P. 761-770.
. Wheeler A.H. Therapeutic uses of botulinum toxin//Am. Fam. Physician.- 1997. - Vol.55.- P.541-548.
. Averbuch-Heller L., Leigh R.J. Medical treatments for abnormal eye movements: pharmacological, optical and immunological strategies//Aust. NZJ Ophthalmol.- 1997. - Vol. 25. - P.7-13.
. Carter S.R., Seiff S.R. Cosmetic botulinum toxin injections//Int. Ophthalmol Clin.- 1997. - Vol. 37. - P. 69-79.
. Maseri A., Andreotti F. Targeting new thrombolytic regimens at specific patient groups: implications for research and cost-containment//Eur. Heart J. - 1997. - Vol. 18. - P.28-35.
. Levine S.R. Thrombolytic therapy for stroke: the new paradigm//Hosp. Pract.- 1997. - Vol. 32. - P.57-73.
. Cherry J.D. Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials//Pediatr. Infect. Dis.- 1997. - Vol. 16. - P. 890-896.
. Michie C.A., Cohen. J. The clinical significance of T-cell superantigens//Trends Microbiol.- 1998. - Vol. 6, №2.- Р. 61-65.
